Alector, Inc. Cash and Restricted Cash
Alector, Inc. (ALEC) had Cash and Restricted Cash of $61.76 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61.76M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.81M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $67.65M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.35M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $61.76M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $78.81M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $67.65M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $78.35M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $46.62M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $39.82M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $34.87M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $38.70M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $49.09M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $74.10M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $76.10M 10-K · filed 2026-02-25 |
| 2023-09-30 | $103.51M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $133.09M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $197.03M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $155.79M 10-K · filed 2025-02-26 |
| 2022-09-30 | $185.70M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $173.74M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $456.09M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $330.62M 10-K · filed 2025-02-26 |
| 2021-09-30 | $518.00M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $127.19M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $112.17M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $51.44M 10-K · filed 2024-02-27 |
| 2020-09-30 | $86.45M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $93.97M 10-Q · filed 2021-08-03 |
| 2020-03-31 | $162.39M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $91.11M 10-K · filed 2023-02-28 |
| 2019-09-30 | $88.45M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $70.68M 10-Q · filed 2020-08-11 |
| 2019-03-31 | $62.43M 10-Q · filed 2020-05-13 |
| 2018-12-31 | $66.94M 10-K · filed 2022-02-24 |
| 2018-09-30 | $43.41M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $50.38M 10-Q · filed 2019-08-12 |
| 2018-03-31 | $37.40M 10-Q · filed 2019-05-13 |
| 2017-12-31 | $32.45M 10-K · filed 2021-02-25 |
| 2016-12-31 | $51.04M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |